The global drug infusion systems market size reached USD 10.56 Billion in 2020 and is expected to register a CAGR of 7.1%, during the forecast period, according to latest analysis by Emergen Research. Increasing demand for safe and precise drug delivery systems is a key driver expected to drive global drug infusion systems market revenue growth over the forecast period. Increasing application of drug infusion systems for chronic pain management is expected to further propel revenue growth of the global drug infusion systems market in the near future. Increasing integration of advanced equipment and up-gradation of drug infusion systems, such as flow monitoring and microï¬‚ow regulators, is expected to boost global drug infusion systems market revenue growth going ahead.
The all-encompassing report on the Drug Infusion Systems market projects the prospective growth of the industry. It gives and extensive analysis of the market size, share, demand, trends, gross revenue, total earnings to draw a forecast of the growth in the years 2020 to 2028. The study estimates the potential growth of the industry and the factors responsible for the expansion of the business. The study highlights the driving forces, restrains and hurdles for the growth of the market.
You Can Download Free Sample PDF Copy of Drug Infusion Systems Market at https://www.emergenresearch.com/request-sample/692
Some Key Highlights From the Report
The open-loop system segment revenue is expected to expand at a significant CAGR during the forecast period. Increasing usage of drug infusion systems with the open-loop system across hospitals is expected to boost revenue growth of this segment going ahead.
The continuous infusion segment is expected to lead in terms of revenue over the forecast period due to increasing usage of continuous infusion type-based drug infusion systems among end-users.
The intravenous segment is expected to lead in terms of revenue over the forecast period due to increasing usage of intravenous route for insulin delivery to insulin-dependent diabetic patients.
The diabetes segment is expected to lead in terms of revenue over the forecast period due to increasing application of drug infusion systems for insulin delivery to diabetics.
Factors such as rising prevalence of chronic diseases and increasing adoption of technologically advanced medical equipment in the healthcare industry in countries in North America is expected to drive growth of the market in the region during the forecast period.
Key players in the market include Medtronic plc, Arcomed Ag, Baxter International Inc., Insulet Corporation, Smiths Group plc, Becton, Dickinson and Company, Halyard Health, Inc., ICU Medical, Inc., Flowonix Medical Inc., and Zyno Medical LLC
Get access to FREE Sample PDF Copy of Drug Infusion Systems Market at https://www.emergenresearch.com/request-sample/692
Control Systems Outlook (Revenue, USD Billion; 2018–2028)
Open Loop System
Closed Loop System
Infusion Type Outlook (Revenue, USD Billion; 2018–2028)
Patient Controlled Infusion
Total Parenteral Nutrition
Administration Route Outlook (Revenue, USD Billion; 2018–2028)
Application Outlook (Revenue, USD Billion; 2018–2028)
End-Use Outlook (Revenue, USD Billion; 2018–2028)
Ambulatory Surgical Centers
Proceed to buy@ https://www.emergenresearch.com/select-license/692
Key questions answered in the report
What will be the market size in terms of value and volume in the next five years?
Which segment is currently leading the market?
In which region will the market find its highest growth?
Which players will take the lead in the market?
What are the key drivers and restraints of the market’s growth?
The report segments the Drug Infusion Systems market on the basis of geography, end-user, end-use, product application, type, share, growth rate and size to reveal where the industry will be in the coming years. The researchers assessing the industry have included the details about the recent decisions and events such acquisition and mergers, collaborations, product launch and investments. Important decisions connected with such events come handy for business owners when positioning their brands in the global market and finalizing the marketing strategies.
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.4. Research Sources
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Drug Infusion Systems Market Segmentation & Impact Analysis
4.1. Drug Infusion Systems Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
18.104.22.168. Stringent environmental regulations
22.214.171.124. Rising need to reduce bacterial or algal contamination in water systems
126.96.36.199. Increasing demand for biocides for municipal water treatment
4.2.3. Market restraints analysis
188.8.131.52. Fluctuating prices of raw material
184.108.40.206. Present challenging economic conditions due to the pandemic
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Drug Infusion Systems Market By Application Insights & Trends, Revenue (USD Million), Volume (Kilo Tons)
Chapter 6. Drug Infusion Systems Market By Product type Insights & Trends Revenue (USD Million), Volume (Kilo Tons)
Chapter 7. Drug Infusion Systems Market Regional Outlook
Chapter 8. Competitive Landscape